Cite

HARVARD Citation

    Reed, N. et al. (2020). Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. Clinical oncology. 32 (5), pp. e145-e153. [Online]. 
  
Back to record